Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.
PHASE2
The present trial is conducted to further assess the efficacy by means of s...
A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE4
The purpose of this study is to assess the effect of aclidinium bromide com...
Status
Completed
Location
Pulmonary Research Institute at the Lung Clinic Grosshansdorf